(Total Views: 652)
Posted On: 08/15/2024 6:17:41 PM
Post# of 154569
Apparently... We have a total of 1000 shareholders.
Leronlimab showed Anti-EARLY tumor activity in patients with CCR5 mTNBC and publication of study results is PENDING.
nTNBC compassionate use study trial is no longer active...publication of results is PENDING.
nTNBC Pre-clinical Development ..the temporal equivalency of this six-week study in mice....may be up to six YEARS in humans.
And as said... in come and get it commercials...and much more.
Leronlimab showed Anti-EARLY tumor activity in patients with CCR5 mTNBC and publication of study results is PENDING.
nTNBC compassionate use study trial is no longer active...publication of results is PENDING.
nTNBC Pre-clinical Development ..the temporal equivalency of this six-week study in mice....may be up to six YEARS in humans.
And as said... in come and get it commercials...and much more.
(3)
(0)
